Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Ductal Carcinoma in Situ|Estrogen Receptor-positive Breast Cancer|Progesterone Receptor-positive Breast Cancer|Stage I Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer
Interventions: DRUG: letrozole|DRUG: zoledronic acid
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins